These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6391904)

  • 1. [Chromosomes and drug resistance of tumors].
    Levina NV
    Eksp Onkol; 1984; 6(2):14-9. PubMed ID: 6391904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA amplification in drug resistant cells and in tumours.
    Stark GR
    Cancer Surv; 1986; 5(1):1-23. PubMed ID: 3297310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene amplification as a target for cancer chemotherapy.
    Snapka RM
    Oncol Res; 1992; 4(4-5):145-50. PubMed ID: 1504374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetic origin of drug resistance in neoplasms: implications for systemic therapy.
    Goldie JH; Coldman AJ
    Cancer Res; 1984 Sep; 44(9):3643-53. PubMed ID: 6744284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1p31, 7q21 and 18q21 chromosomal aberrations and candidate genes in acquired vinblastine resistance of human cervical carcinoma KB cells.
    Wang J; Tai LS; Tzang CH; Fong WF; Guan XY; Yang M
    Oncol Rep; 2008 May; 19(5):1155-64. PubMed ID: 18425371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle arrest induced by pisosterol in HL60 cells with gene amplification.
    Burbano RR; Lima PD; Bahia MO; Khayat AS; Silva TC; Bezerra FS; Andrade Neto M; de Moraes MO; Montenegro RC; Costa-Lotufo LV; Pessoa C
    Cell Biol Toxicol; 2009 Jun; 25(3):245-51. PubMed ID: 18465199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amplification of portions of the genome in mammalian somatic cells resistant to colchicine. I. Chromosome 4 trisomy in the development of gene amplification and colchicine resistance in Djungarian hamster cells].
    Kopnin BP
    Genetika; 1982 Sep; 18(9):1503-12. PubMed ID: 6890494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gains of 1q21-q22 and 13q12-q14 are potential indicators for resistance to cisplatin-based chemotherapy in ovarian cancer patients.
    Kudoh K; Takano M; Koshikawa T; Hirai M; Yoshida S; Mano Y; Yamamoto K; Ishii K; Kita T; Kikuchi Y; Nagata I; Miwa M; Uchida K
    Clin Cancer Res; 1999 Sep; 5(9):2526-31. PubMed ID: 10499629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of cellular oncogenes in cancer cells.
    Alitalo K
    Med Biol; 1984; 62(6):304-17. PubMed ID: 6398390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chromosomal changes in cancers].
    Sakaki MS
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):781-8. PubMed ID: 6372697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer drug resistance: the central role of the karyotype.
    Duesberg P; Li R; Sachs R; Fabarius A; Upender MB; Hehlmann R
    Drug Resist Updat; 2007; 10(1-2):51-8. PubMed ID: 17387035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic study of stable inheritable cell resistance to colchicine. Chromosomal and hybridization analysis].
    Kopnin BP
    Genetika; 1982 Oct; 18(10):1693-702. PubMed ID: 6890923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative genomic hybridization study of genetic changes associated with vindesine resistance in esophageal carcinoma.
    Obara K; Ghazizadeh M; Shimizu H; Arai R; Tenjin T; Suzuki S; Moriyama Y; Kawanami O
    Int J Oncol; 2002 Feb; 20(2):255-60. PubMed ID: 11788885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similarity in dynamics of single or double minute chromosomes incidence and number of chromosomal aberrations during long-term treatment of a human cell line with methotrexate.
    Vítek JA
    Neoplasma; 1987; 34(6):665-70. PubMed ID: 3431607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of drug resistance.
    Longley DB; Johnston PG
    J Pathol; 2005 Jan; 205(2):275-92. PubMed ID: 15641020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs.
    Fojo T
    Drug Resist Updat; 2007; 10(1-2):59-67. PubMed ID: 17350322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal alterations cause the high rates and wide ranges of drug resistance in cancer cells.
    Li R; Hehlman R; Sachs R; Duesberg P
    Cancer Genet Cytogenet; 2005 Nov; 163(1):44-56. PubMed ID: 16271955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene amplification, drug resistance, and cancer.
    Schimke RT
    Cancer Res; 1984 May; 44(5):1735-42. PubMed ID: 6713376
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in cancer therapeutics: chemotherapy.
    DeVita VT
    Prog Clin Biol Res; 1983; 132A():47-69. PubMed ID: 6634746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gene amplification and chromosomal rearrangements during acquisition of cellular resistance to the antimetabolite coformycin].
    Debatisse M; Toledo F; Buttin G
    Bull Cancer; 1994 May; 81(5):372-80. PubMed ID: 7749213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.